Summary. The involvement of nitric oxide as an intracellular messenger in the control of insulin secretion from pancreatic Beta cells was studied in rat islets of Langerhans by measuring: (i) nitric oxide generation in response to physiological insulin secretagogues; (ii) the effects of inhibitors of nitric oxide synthesis on insulin secretory responses to physiological secretagogues, and on insulin synthesis; (iii) changes in islet cyclic guanosine monophosphate in response to secretagogues; (iv) the effects of exogenous cyclic guanosine monophosphate and dibutyryl cyclic guanosine monophosphate on insulin secretion from electrically permeabilised islets and from intact islets, respectively. These studies produced no evidence that nitric oxide generation is required for the initiation of insulin secretion by common secretagogues. However, the results of our experiments suggest that the generation of nitric oxide may be involved in long-term, glucose-dependent increases in cyclic guanosine monophosphate content of islet cells, although the physiological relevance of these changes requires further investigation.
The release of insulin from pancreatic Beta cells is closely regulated by circulating concentrations of nutrients, such as glucose, and by certain hormones and neurotransmitters. These different types of secretagogues appear to control the secretory process by changing the concentration/availability of a number of intracellutar regulatory molecules. Changes in Beta-cell cytosolic Ca 2 ÷, whether by an influx of extracellular Ca 2 + or a liberation of intracellular stores of Ca 2+, are thought to be of prime importance in the initiation of insulin secretion [1] . Secretory responses to Ca 2÷ can be modified by cyclic nucleotides and products of phospholipid hydrolysis, such as diacylglycerols, or arachidonic acid or its metabotites, or both [1] . Nitric oxide (NO), recently identified as endotheliumderived relaxing factor [2] , acts as a signalling molecule in many cell types and there have been recent reports that NO may be generated within the islets of Langerhans [3] [4] [5] and insulin-secreting turnout cells [4, 5] . NO is generated from the amino acid arginine by nitric oxide synthase (NO-synthase), an enzyme activity which appears to exist in two distinct forms, both of which require NADPH [6] . One form of NO synthase, which is found in endothelial cells, is constitutively expressed and is activated by Ca 2 + in sub-micromolar concentrations [6] . Our previous studies using electrically permeabilised islets have demonstrated that increases in cytosolic Ca 2+ alone are sufficient to initiate insulin secretion [7, 8] . The constitutive, Ca2+-sensitive NO-synthase therefore offers a potential regulatory mechanism for Beta-cell secretory responses to Ca 2+-mobilising secretagogues such as glucose or cholinergic agonists. The other form of NO-synthase, which is found in macrophages, is inducible, insensitive to changes in intracellular Ca 2 ÷, and generates large amounts of NO in an unregulated manner after induction [6] . In the present study we have used several experimental approaches to determine the role, if any, of NO in the initiation of Beta-cell secretory responses.
Several methods for detecting the generation of NO have been described. For example, chemical measurements of nitrites in an incubation medium give an indication of prior NO production [3] . Other assays for NO production are based on measuring increases in guanylate cyclase activity or guanosine 3', 5'-cyclic monophosphate (cyclic GMP) concentrations in target tissues [9] , or by measuring some functional consequence of elevated cyclic GMP, such as relaxation of smooth muscle [2, 10] . Alternatively, an on-line estimation of NO generation can be obtained by monRoring the conversion of oxy-haemoglobin (oxy-Hb) to methaemoglobin (met-Hb) as a result of the reaction of NO with the haem moiety of haemoglobin, with the resultant production of nitrate ions [9] . Using this approach we have directly compared insulin re-lease and NO production from perifused rat islets in response to nutrient and non-nutrient secretagogues.
Analogues of arginine, such as NG-monomethyl-L-arginine (NMA) or N-nitro-c-arginine methyl ester (NAME) are competitive inhibitors of both isoforms of NO synthase, albeit with differing potencies [11] . We have used these arginine analogues to determine whether inhibition of NO synthase activity results in a parallel inhibition of insulin secretion from isolated rat islets of Langerhans. A major intracellular target for NO appears to be the haem moiety of soluble guanylate cyclase [12] . The reaction of NO with haem causes the activation of guanylate cyclase, leading to elevated levels of intracellutar cyclic GME We have therefore measured the effects of insulin secretagogues, and of N/vIA mid NAME, on the accumulation of endogenous cyclic GMP in islets. To determine whether NO-induced changes in islet cyclic GMP could be involved in regulating the secretory process, we have measured the effects of exogenous cyclic GMP on Ca ~ +-induced insulin secretion from electrically permeabilised islets, and of dibutyryl cyclic GMP (db-cyclic GMP) on glucose-induced insulin secretion from intact islets.
Materials and methods

Materials
with 4 gtmol/1 oxy-Hb with an absorption maximum of 415 nm, prepared according to the method of Feeliscli and Noack [9] . The molsidomine metabotite SIN-1 (0.1-10gmol/1), which spontaneously generates NO, was used to validate and to calibrate the system. Changes in absorbance were converted into secretion rates for NO using a molar extinction coefficient of 60 mmol. 1-~. cm -a measured for oxy-Hb in these studies, as described [9] .
Measurements of islet cyclic nucleotide content
Groups of 50-100 islets were incubated (15 or 30 min, 37°C) in physiological buffer [14] containing the insulin secretagogue of interest plus 100 gmol/l isobutylmethylxanthine (IBMX). After incubation the islets were pelleted by brief centrifugation (9000 g, 15 s), the supernatant was removed for insulin assay and the islet pellet was extracted by boiling (3 min) and sonication in sodium acetate buffer. Cyclic GMP was measured by radioimmunoassay using an antiserum raised against cyclic 2'-O-succinyl-GMP which was kindly donated by Dr. D. Sugden, Biomedical Sciences Division, King's College London. Cyclic GMP standards and samples (50 gl) were acetylated before inclusion in the assay by addition of 5 gl triethytamine: acetic anhydride (2:1 v/v), and cyclic 2'-O-succinyl-GMP 3-[z25I] iodotyrosine was used as the radiolabelled tracer. Incubation was for 48 h at 4°C and antibody-bound cyclic GMP was precipitated by 12% (weight/volume, w/v) polyethylene glycol. Under these conditions the detection limit of the assay was approximately 0.5 fmol cyclic GMP per tube, with a useful range of 0.5-250 fmol cyclic GMP per tube. In some experiments, islet cyclic AMP content was measured by radioimmunoassay, as previously described [16] . 
Tissue isolation and culture
Islets of Langerhans were isolated from fed Wistar rats by collagenase digestion of the exocrine pancreas [13] , and incubated (37 °C, 95 % air/5 % CO2) for 16-20 h in RPMI 1640 culture medium containing 2 mmol/1 glucose or 11 mmol/1 glucose, and supplemented with 10 % (volume/volume, v/v) fetal calf serum, 100 gg of streptomycin/ml, 100 units of penicillin/ml and, for some experiments, 100 gmol/l or 200 pmol/l NMA or NAME. Before use in secretion experiments, islets were thoroughly washed and incubated (60 min, 37 °C) in a physiological salt solution [14] containing 2 mmol]l glucose and, where appropriate, NMA or NAME at the same concentration as was present during the culture period.
Isolated porcine aortic endothelial cells were subcultm-ed once, grown to confluence on microcarrier beads and transferred to 0.5 ml columns (-2.5 x 10 6 cells) as described [15] , for perifusion at 0.8 ml/min with Krebs buffer supplemented with the test substances of interest.
NO measurements
NO release from perifused islets and porcine aortic endothelial cells was assessed by measuring the conversion of oxy-Hb to met-Hb by continuous monitoring of the difference spectrum of the perifusate at 401 and 411 nm using a double wavelength spectrophotometer, essentially as described [9] . The perifusion buffer was supplemented Insulin secretion studies (a) Perifusions. Groups of 800-1500 islets (approximately 2-4 x 106 cells) were transferred to Millipore Swinnex filter chambers containing 1 gm mesh filters and perifused at a flow rate of 0.8 ml/min with Krebs buffer supplemented with the test substances of interest. NO generation by the islets was continuously assessed as described above and fractions were collected at 1-min intervals for measurement of insulin release by radioimmunoassay [t7].
(b) Static incubations.
To measure the effects of NMA, NAME or db-cyclic GMP on insulin secretion, groups of three islets were incubated (30 min, 37°C) in 0.6 ml of a physiological salt solution supplemented with 2, 10 or 20mmol/t glucose, 2mmol/1 CaC12, 0.5 mg/ml of bovine serum albumen and the test substances of interest, and insulin secretion was measured by radioimmunoassay.
(c) Electrically permeabilised islets. The effects of exogenous cyclic
GMP on insulin secretion were investigated using islets permeabilised by high voltage discharge, as previously described [7] . Groups of five electrically permeabilised islets were incubated (30 rain, 37 °C) in a glutamate-based Ca-' +/EGTA buffer containing 50 nmol/1 or 10 lxmol/1 Ca 2+ in the presence or absence of cyclic GMP or cyclic AMR
Insulin content and synthesis"
The effects of NMA and NAME on (pro)insulin synthesis were assessed by measuring the incorporation of a radiolabelled amino acid into (pro)insulin after immunoprecipitation of islet extracts. Islets were incubated for 20 h in RPMI t640 medium containing 2 mmol/t or 11mmol/l glucose supplemented with NMA or NAME (200 gmol~). Groups of 50 islets were further incubated (100 gl, 3h,37°C) in fresh medium supplemented with [35S]-cysteine (150 gCi/ml; > 1000 Ci/mmol). The islets were washed (2 x 1 mt) and incubated (1 h, 37 °C) in RPM11640 medium (2 mmol/1 glucose) supplemented with 2 mmol/1 cysteine. After two further washes (2 x 1 ml) with RPM11640 supplemented with 2 mmol/1 cysteine the Anti-insulin serum [17] was added (2 gl neat serum/100 gl sample) and samples were incubated at 4°C for 24 h. (Pro)insulin bound to anti-insulin antibodies was precipitated by the addition of Pansorbin (20 gl) and incubation with constant mixing (20 °C, 2 h), followed by precipitation of the Pansorbin by centrifugation (9000 g, 1 min). The resulting pellet was washed ( x 4, 4°C) with lysis buffer and uS incorporation into immunoprecipitated proteins in the pellets was measured by liquid sdntillation spectroscopy. In parallel experiments, islet insulin content was measured by radioimmunoassay after extraction in acidified ethanol (10 islets/200 gt).
Results
Effects of insulin secretagogues on islet NO production
Increasing the concentration of glucose in the perifusate from 2 mmol/1 to 10 mmol/l caused a rapid increase in insulin secretion from perifused islets, as shown in Figure 1 (lower traces). This initial, rapid rise in insulin secretion represents the first, transient phase of the secretory response to nutrient secretagogues. Glucose-induced insulin secretion was further enhanced by the presence of the cholinergic agonist carbachol (CCh, 500 gmol/1) or by arginine (Arg, 10 mmol/1). However, neither glucose alone, glucose plus CChn or glucose plus arginine stimulated the release of detectable amounts of NO from these perifused islets, as judged by the unchanged signal from the oxy-Hb/met-Hb difference spectra shown on Figure 1 (upper traces). In similar experiments, insulin secretion was significantly stimulated by perifusion with buffers containing a higher concentration of arginine (20 mmol/1, 161 _+ 12 % control, mean _+ SEM, n = 6, p < 0.01), or the protein kinase C activator, phorbol myristate acetate (PMA, 500 nmol/1, 160_+24% control, n = 6, p <0.05) again without detectable effects on NO generation by the islets. In contrast, NO generation was readily detected in parallel experiments using porcine aortic endothelial cells. Assuming that SIN-1 has a stoichiometric effect to that of NO in this system [9] , the lower detection limit for NO generation in these experiments was less than 10 pmol NO. min-1.106 cells-1.
Effects" of insulin secretagogues on islet cyclic GMP content
Freshly isolated rat islets contained low but detectable amounts of cyclic GMP, which were approximately 100-fold lower than unstimulated islet cyclic AMP content. However, the results shown in Table 1 demonstrate that islet cyclic GMP content increased markedly (5-10 fold) after 20 h of culture in RPMI 1640 medium containing 11mmol/1 glucose. Short incubations (15m in) with 20 mmol/1 glucose caused significant increases in islet cyclic AMP content (2 mmolFl glucose, 14.5 + 1.0 fmoI/islet; 20 mmol/1 gIucose, 27.7 + 1.2, mean + SEM, n = 10, p < 0.01), but 15-min incubations with stimulatory concentrations of glucose (20 mmol/1), arginine (10 mmolfl) or CCh (500 gmol/1) were without detectable effects on the cyclic GMP content of either freshly isolated islets or of cultured islets, as shown in Table 1 The marked increases in islet cyclic GMP observed after the 20 h culture period were dependent upon the concentration of glucose in the culture medium, as shown in Figure 3 . Thus, increases in cyclic GMP content were observed after 20 h culture in RPMI 1640 containing 11 mmol/i glucose, but not after 20 h culture in the same medium containing 2 mmol/1 glucose. Furthermore, these glucose-dependent increases in islet cyclic GMP could be totally abolished by the presence of either NMA or NAME (200 gmol/1) in the culture medium (Fig. 3) . In the experiment shown in Figure 3 , NMA (but not NAME) reduced islet cyclic GMP content below that measured in control islets (2 mmolfl glucose). However, in four separate experiments of this type NMA (200 gmol/1) did not consistently produce such a reduction in basal levels of cyclic GMP (control, 2 mmol/l glucose, 173 + 27 amol/islet; + NMA, 146 + 38,p > 0.2, n = 4).
Effects" of NO synthase inhibitors on insulin secretion and synthesis
The NO synthase inhibitors, NMA and NAME, did not inhibit glucose-induced insulin secretion during a 30-min incubation in the absence of exogenous arginine, as shown in Figure 4 . Under these static incubation conditions, insulin secretion by the islets reflects both the transient first phase and the prolonged second phase responses to nutrient secretagogues. When used at concentrations well above those known to inhibit NO synthase activity [11] , NMA had no consistent effect on glucose-induced (10 mmol/] or 20 mmol/1) insulin secretion (Fig. 4, upper  panel) . In similar experiments, NAME was also without inhibitory effects on glucose-induced insulin secretion, even when used at concentrations up to I mmol/1 (Fig. 4,  lower panel) .
The failure of NMA and NAME to inhibit insulin secretion was not because of too short an exposure to these agents, since even 20-24 h exposure to NMA or NAME (200 gmol/1) did not inhibit subsequent insulin secretory responses, although such treatment did have marked effects on islet cyclic GMP content (Fig.3) . Figure 5 shows that prolonged treatment with NMA or NAME (in the presence of 11 mmol/1 glucose) did not affect basal insulin release (2 mmol/1 glucose), nor secretory responses to 20 mmol/1 glucose or to arginine (20 mmol/l). In similar experiments, prolonged treatment with NMA (200 gmol/1, 20 h) did not affect insulin secretion induced by the cholinergic agonist CCh in the presence of 10mmol/1 glucose (controls, 10mmol/t glucose+ 500 gmol/1 CCh, 392 _+ 44 % of secretion with 10 mmol/1 glucose alone; NMA-treated, 10 mmol/1 glucose + 500gmol/1 CCh, 332+28%, mean_+SEM, n=9, p > 0.2).
Prolonged treatment with NMA or NAME (200 gmol/1) had no detectable effect on insulin biosynthesis, as shown in Figure 6 . Thus, incubation for 20 h in RPMI 1640 medium containing 11 mmol/1 glucose produced a small but significant (p < 0.02) increase in islet insulin content when compared to control islets cultured in the presence of 2 mmol/1 glucose, but insulin content was neither enhanced nor diminished by the presence of NMA or NAME. Similarly, incorporation of [35S]-cysteine into (pro)insulin was significantly enhanced by exposure to 11 mmolft glucose when compared to control islets exposed to 2 mmol/1 glucose, but this glucose-induced stimu- Fig.3 . Cyclic guanosine monophosphate (cyclic GMP) in cultured islets: effects of glucose, NG-monomethyl-L-arginine (NMA) and Nnitro-L-arginine methyl ester (NAME). The figure shows cyclic GMP levels in freshly isolated islets ([]) and in islets cultured for 20 h in RPM11640 medium containing 2 or 11 mmol/t glucose in the presence or absence of NMA or NAME, as shown. Culture in medium containing 2 mmol]l glucose was without effect on islet cyclic GMP (p > 0.2), whereas culture in the same medium containing tl mmol/1 glucose caused marked increases in islet cyclic GMP (p <0.0t). The glucose-induced elevations in islet cyclic GMP were totally inhibited by both NAME and NMA. Bars show means + SEM, n = 8 or 9
lation of insulin biosynthesis was not affected by the presence of either NMA or NAME (Fig. 6) . Figure 7 shows the effects of db-cyclic GMP on insulin secretion from intact islets (upper panel) and of cyclic GMP from electrically permeabilised islets (lower panel). In intact islets, insulin secretion was markedly stimulated in the presence of 20mmolfl glucose (plus 100gmol/1 IBMX). However, concentrations of up to 5 mmol/1 db-cyclic GMP had no effect on either basal (2 mmoI/1 glucose) or stimulated (20 mmol/1 glucose) insulin secretion (Fig. 7 , upper panel). In similar experiments, i mmol/1 dibutyDq cyclic AMP (db-cyclic AMP) had no effect on basal insulin secretion, but caused a marked enhancement of glucose (20 mmol/1)-induced secretion. Electrically permeabilised islets can be used to study the effects of small, normally impermeant molecules, which rapidly enter the Beta cells across the electrically permeabilised plasma membranes [7, 8] . As shown in Figure 7 (lower panel) , increasing the concentration of Ca 2+ in the incubation medium, and thus in the intracellular compartment, from 50 nmol/1 to 10 gmol/1 stimulated insulin secretion from electrically permeabilised islets. However, the inclusion of cyclic GMP in the incubation medium at concentrations of up to 500 gmol/1 had no effect on insulin secretion at either the substimulatory (50 nmol/1) or the stimulatory (10 gmot/1) concentration of Ca 2 +. In contrast, cyclic AMP (100 gmol/1) significantly R M. Jones et al.: NO and insulin secretion enhanced insulin secretion from permeabilised islets at both 50 nmol/1 and 10 gmol/1 Ca 2 +.
Effects of cyclic GMP and db-cyclic GMP on insulin secretion
Discussion
The physiological importance of NO as a cellular regulator is now widely accepted. In addition to its role as a regulator of vascular tone as the endothelium derived relaxing factor [2] , NO is known to act as a cytotoxic agent produced by activated macrophages [18] [19] [20] . Evidence is also accumulating that NO may have widespread functions as a cellular regulator including, for example, as a neurotransmitter/neuromodulator in the central nervous system [21] , or an anti-aggregatory second messenger in platelets [6] .
In this context, we were interested to note that the constitutive form of NO synthase is Ca2+-activated [6, 21] since an initial event in the response of Beta cells to nutrient secretagogues is a rapid influx of extracellular Ca 2 + through voltage sensitive Ca 2+ channels [22] . The consequent increase in cytosolic Ca 2 + might be predicted to ac- , n = 9) of islets cultured for 20 h in media containing 2 mmol/1 or 11 retool/1 glucose in the presence or absence of NMA or NAME, as indicated. Exposure to 11 mmol/1 glucose significantly increased 35S-cysteine incorporation and insulin content (p < 0.01 andp < 0.05, respectively). NMA and NAME had no significant effects on glucose-induced insulin biosynthesis or insulin content (p > 0.2) tivate intracellular Ca2+-sensitive enzymes, as is thought to happen to phospholipase C in the Beta cell [23] . Furthermore, constitutive NO synthase requires NADPH [6, 21] and it is known that the metabolism of glucose, which is required for its secretagogue actions, produces rapid increases in NADPH levels within Beta cells [24] . However, in the present studies in which we simultaneously measured NO production and insulin secretion from rat islets we were consistently unable to measure NO gener-ation by islets in response to Beta-cell Ca2+-mobilising stimuli such as glucose, arginine or carbachol. Our parallel estimates of NO generation by porcine aortic endothelial cells in response to bradykinin are in general agreement with those reported by groups using on-line bioassay measurement of NO [2, 10] , and suggest that if NO is generated by stimulated islet cells then the rate of production is at least of an order of magnitude less than that of endothelial cells in our experiments.
It cannot be entirely excluded that the insulin secretagogues did stimulate NO production by the Beta ceils, but at rates below the detection limit of our assay system. Since one of the major effects of NO is to activate guanylate cyclase and thus increase cyclic GMP in target cells [12] , we measured the effects of Ca 2 +-mobilising secretagogues on islet cyclic GMP content. Our measurements clearly demonstrated that the initiation of secretory responses to glucose, arginine or CCh was not accompanied by concomitant increases in islet cyclic GMR although longer exposures to stimulatory concentrations of glucose did produce increases in islet cyclic GME There is no clear consensus on the effects of glucose and other secretagogues on cyclic GMP in islets or insulin-secreting tumour cells. Thus, stimtflatory concentrations of glucose have been reported to cause rapid (2-3 min) increases in islet cyclic GMP [5] , in contrast to our measurements of unchanged levels of islet cyclic GMP after 15-rain exposure to secretagogues. However, in some studies islet cyclic GMP was unchanged after exposure to stimulatory concentrations of glucose for up to 60 min [25] [26] [27] , whereas in others, including the present Study, exposure to glucose for 30 rain or longer increased cyclic GMP content [4, 28] . Whatever the reasons for these discrepancies, it seems likely that the marked glucose-dependent increases in cyclic GMP seen in the present studies after 20 h exposure to a stimulatory concentration of glucose were secondary to increased NO production since they were totally blocked by NMA or NAME. However, despite these effects of NO synthase inhibition on islet cyclic GME neither short-term nor prolonged exposure to NMA or NAME inhibited Beta-cell secretory responses, in accordance with previous studies using several NO synthase inhibitors [3, 29, 30] . Although there is still some disagreement about the importance of cyclic GMP in the regulation of insulin secretion [4, 28] , clear dissociations between elevations in islet cyclic GMP and insulin secretion have been reported [26, 28] . In the present studies we too were unable to demonstrate an important role for cyclic GMP in the control of insulin secretion in experiments in which we supplied intact or permeabilised islets with exogenous cyclic GMR Our results therefore suggest that secretory responses of Beta cells to glucose, arginine and CCh are not dependent upon the activation of NO synthase, nor upon the intracellular concentrations of cyclic GME Insulin biosynthesis, like insulin secretion, is a glucose-sensitive process and high concentrations of db-cyclic GMP have been reported to cause small increases in insulin synthesis in rat islets [25] . However, in our experiments treatment of islets with NMA or NAME prevented glucose-induced rises in cyclic GMP without affecting the stimulation of insufin biosynthesis by glucose, suggesting that changes in Beta-cell cy- . Db-c AMP had no effect on basal secretion, but markedly enhanced glucose-stimulated insulin secretion (p < 0.01). Bars show means + SEM, n = 9. Lower panel: In experiments using electrically" permeabilised islets, cyclic GMP had no effect on basal (50 nmol/1 Ca 2+, [-] ) or Ca 2+ -induced (10 gmol/1, [~) insulin secretion (p > 0.2 at all concentrations of cyclic GMP). In contrast, cyclic AMP significantly increased both basal and Ca z+-stimulated insulin secretion (p < 0.01). Bars show mean + SEM, n=9
clic GMP do not regulate glucose-induced insulin biosynthesis. It is therefore unclear what, if any, physiological function(s) are subserved by the increases in islet cyclic GMP observed in our experiments. The time-course and susceptibility to NO-synthase inhibitors suggest that the changes in islet cyclic GMP are secondary to the actions of an in-R M. Jones et al.: NO and insulin secretion ducible form of NO synthase, and the glucose-dependence of the changes suggest an effect in the glucose-sensitive Beta cell. However, islets comprise a heterogenous population of endocrine and non-endocrine cells and we cannot exclude a glucose-sensitive activation of NO synthase in non-endocrine cells. In particular, NO has been implicated in the cytokine-induced destruction of pancreatic Beta cells which is thought to be associated with the development of diabetes mellitus [3, 18, 30, 31] . Macrophages, in which NO synthase is the inducible form, are activated by cytokines and may act within islets as the NO generating cells for Beta-cell destruction [18, 31] . The cytotoxic effects of NO on Beta cells are thought to be mediated by non-haem iron-containing proteins such as aconitase [30] , rather than by the haemoprotein guanylate cyclase. The changes in islet cyclic GMP levels seen in our experiments are unrelated to insulin secretion, but are possibly an inescapable consequence of guanylate cyclase activation secondary to elevated NO levels in the islet.
